Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A question.

A question.

posted on Oct 12, 2009 11:15PM

If the BoD has made one bad decision, followed by another, followed by yet more, the relationship with TPL leaves so much to be desired, and berating the BoD for years on various stock boards has had no impact, what great insight makes an investment in PTSC so obvious that it outweighs all of the above?

Obviously, it can't be potential licensing revenues generated by TPL, can it?

.

.

Be well

Share
New Message
Please login to post a reply